Skip Nav Destination
Issues
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Review
Advances in Brief
Reversal of GSTP1 CpG Island Hypermethylation and Reactivation of π-Class Glutathione S-Transferase (GSTP1) Expression in Human Prostate Cancer Cells by Treatment with Procainamide1
Xiaohui Lin; Kekule Asgari; Mathew J. Putzi; Wesley R. Gage; Xiang Yu; Brian S. Cornblatt; Arunima Kumar; Steven Piantadosi; Theodore L. DeWeese; Angelo M. De Marzo; William G. Nelson
Aberrant Promoter Methylation Profile of Bladder Cancer and Its Relationship to Clinicopathological Features1
Riichiroh Maruyama; Shinichi Toyooka; Kiyomi O. Toyooka; Kenichi Harada; Arvind K. Virmani; Sabine Zöchbauer-Müller; Alfredo J. Farinas; Funda Vakar-Lopez; John D. Minna; Arthur Sagalowsky; Bogdan Czerniak; Adi F. Gazdar
Biochemistry and Biophysics
Carcinogenesis
Clinical Investigations
Normalization of Elevated Hepatic 8-Hydroxy-2′-Deoxyguanosine Levels in Chronic Hepatitis C Patients by Phlebotomy and Low Iron Diet1
Junji Kato; Masayoshi Kobune; Tokiko Nakamura; Ganji Kuroiwa; Kohichi Takada; Rishu Takimoto; Yasuhiro Sato; Koshi Fujikawa; Minoru Takahashi; Tetsuji Takayama; Tatsuru Ikeda; Yoshiro Niitsu
Endocrinology
Epidemiology and Prevention
Experimental Therapeutics
Simultaneous Inhibition of Glioma Angiogenesis, Cell Proliferation, and Invasion by a Naturally Occurring Fragment of Human Metalloproteinase-21
Lorenzo Bello; Valeria Lucini; Giorgio Carrabba; Carlo Giussani; Marcelle Machluf; Mauro Pluderi; Demetrios Nikas; Jianping Zhang; Giustino Tomei; Roberto M. Villani; Rona S. Carroll; Andreas Bikfalvi; Peter M. Black
Evaluation of Farnesyl:Protein Transferase and Geranylgeranyl:Protein Transferase Inhibitor Combinations in Preclinical Models
Robert B. Lobell; Charles A. Omer; Marc T. Abrams; Hema G. Bhimnathwala; Mary Jo Brucker; Carolyn A. Buser; Joseph P. Davide; S. Jane deSolms; Christopher J. Dinsmore; Michelle S. Ellis-Hutchings; Astrid M. Kral; Dongming Liu; William C. Lumma; Samuel V. Machotka; Elaine Rands; Theresa M. Williams; Samuel L. Graham; George D. Hartman; Allen I. Oliff; David C. Heimbrook; Nancy E. Kohl
Immunology
CD40 Cross-Linking Bypasses the Absolute Requirement for CD4 T Cells during Immunization with Melanoma Antigen Gene-modified Dendritic Cells1
Antoni Ribas; Lisa H. Butterfield; Saral N. Amarnani; Vivian B. Dissette; Donald Kim; Wilson S. Meng; Gustavo A. Miranda; He-Jing Wang; William H. McBride; John A. Glaspy; James S. Economou
Molecular and Genetics
The FOXP1 Winged Helix Transcription Factor Is a Novel Candidate Tumor Suppressor Gene on Chromosome 3p1
Alison H. Banham; Nigel Beasley; Elias Campo; Pedro L. Fernandez; Carrie Fidler; Kevin Gatter; Margaret Jones; David Y. Mason; John E. Prime; Philippe Trougouboff; Katrina Wood; Jacqueline L. Cordell
Tumor Biology
Deleted in Malignant Brain Tumors 1 Is a Versatile Mucin-like Molecule Likely to Play a Differential Role in Digestive Tract Cancer1
Jan Mollenhauer; Stephan Herbertz; Burkhard Helmke; Gaby Kollender; Inge Krebs; Jens Madsen; Uffe Holmskov; Karin Sorger; Liane Schmitt; Stefan Wiemann; Herwart F. Otto; Hermann-Josef Gröne; Annemarie Poustka
In Memoriam
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.